FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21701011000001107: Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71838101000001115 Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78950201000001110 Aizea 75microgram tablets (Besins Healthcare (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Is a Product containing precisely desogestrel 75 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has active ingredient Desogestrel false Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has specific active ingredient Desogestrel true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Is a Aizea true Inferred relationship Existential restriction modifier
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) 84 tablet 3 x 28 tablets Has AMP True Aizea 75microgram tablets (Marlborough Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start